MedTrace Logo

AB-1005 Long-Term Follow-up Study

NCT07081841 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2025-10-02

No results posted yet for this study

Summary

This is an observational, long term, follow-up study for participants with Parkinson's disease (PD) or Multiple System Atrophy-Parkinsonian subtype (MSA-P) who participated in prior interventional studies with AB-1005. It is intended to better understand the long-term safety of AB-1005, how well tolerated it is and how long lasting the effects are.

Conditions

Interventions

OTHER

Observation

This is an observational study in which safety laboratories and non-invasive routine clinical assessments are conducted to gauge long term safety and efficacy.

Sponsors & Collaborators

  • AskBio Inc

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-04
Primary Completion
2037-09-30
Completion
2038-03-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07081841 on ClinicalTrials.gov